• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket

    6/10/24 5:59:44 AM ET
    $AIU
    $BCDA
    $CAPT
    $CLEU
    Other Consumer Services
    Real Estate
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Get the next $AIU alert in real time by email

    Shares of KKR & Co. Inc. (NYSE:KKR) rose sharply in today's pre-market trading after it was announced the company will join the S&P 500.

    S&P Dow Jones Indices announced late Friday changes to various S&P indices, coinciding with the quarterly rebalance. KKR will take the place of Comerica Inc. (NYSE:CMA) in the broader gauge.

    KKR & Co. shares jumped 10.4% to $108.15 in the pre-market trading session.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Big Tree Cloud Holdings Limited (NASDAQ:DSY) rose 165% to $5.05 in today's pre-market trading.
    • New Horizon Aircraft Ltd. (NASDAQ:HOVR) gained 90.1% to $1.37 in pre-market trading after declining around 8% on Friday.
    • Spectaire Holdings Inc. (NASDAQ:SPEC) shares gained 59.3% to $0.6770 in pre-market trading after jumping over 15% on Friday.
    • Presto Automation Inc. (NASDAQ:PRST) shares rose 35.1% to $0.1204 in pre-market trading after surging 17% on Friday.
    • Meta Data Limited (NYSE:AIU) gained 34.5% to $0.5651 in pre-market trading after dipping 19% on Friday.
    • Nisun International Enterprise Development Group Co., Ltd (NASDAQ:NISN) shares rose 13.6% to $3.83 in pre-market trading after the company said it has established a daily supply capacity of over 20 million eggs.
    • Captivision Inc. (NASDAQ:CAPT) rose 13.5% to $3.40 in pre-market trading after declining around 12% on Friday.
    • Galmed Pharmaceuticals Ltd (NASDAQ:GLMD) shares climbed 8.7% to $0.38 in pre-market trading after declining 5% on Friday.
    • Forward Air Corp (NASDAQ:FWRD) gained 7.1% to $22.13 in pre-market trading after gaining around 7% on Friday.

    Losers

    • Sunshine Biopharma, Inc. (NASDAQ:SBFM) shares declined 33.7% to $0.37 in pre-market trading.
    • Roma Green Finance Limited (NASDAQ:ROMA) shares declined 18% to $0.4085 in pre-market trading. Roma Green Finance filed For offering in a best efforts self-underwritten offering of up to 3.6 million of ordinary shares.
    • Versus Systems Inc. (NASDAQ:VS) shares dipped 17.3% to $1.48 in pre-market trading after jumping over 8% on Friday.
    • China Liberal Education Holdings Limited (NASDAQ:CLEU) shares fell 16.8% to $2.66 in pre-market trading after jumping 58% on Friday.
    • Cumulus Media Inc (NASDAQ:CMLS) shares fell 15.2% to $2.01 in pre-market trading after jumping around 22% on Friday.
    • Venus Concept Inc. (NASDAQ:VERO) shares fell 15.1% to $0.7899 in pre-market trading after jumping 50% on Friday.
    • Virax Biolabs Group Limited (NASDAQ:VRAX) shares fell 14.7% to $1.68 in pre-market trading.
    • Trinity Place Holdings Inc. (NYSE:TPHS) fell 14.5% to $0.15 in pre-market trading after jumping 45% on Friday.
    • Sify Technologies Limited (NASDAQ:SIFY) shares declined 10.7% to $0.7413 in pre-market trading after the company announced intent to delist ADS Rights from the Nasdaq Capital Market.
    • BioCardia, Inc. (NASDAQ:BCDA) shares fell 9.4% to $3.37 in pre-market trading. On Friday, BioCardia announced it received approval from the United States Patent Office for its application entitled, "Radial and Transendocardial Delivery Catheter."

    Now Read This: Investor Optimism Improves Slightly Following Jobs Data; US Stocks Record Weekly Gains

    Get the next $AIU alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AIU
    $BCDA
    $CAPT
    $CLEU

    CompanyDatePrice TargetRatingAnalyst
    KKR & Co. Inc.
    $KKR
    2/24/2026$137.00Outperform
    RBC Capital Mkts
    KKR & Co. Inc.
    $KKR
    1/28/2026$144.00Hold → Buy
    HSBC Securities
    KKR & Co. Inc.
    $KKR
    1/14/2026$131.00Buy → Hold
    TD Cowen
    KKR & Co. Inc.
    $KKR
    12/11/2025$176.00Buy
    UBS
    Comerica Incorporated
    $CMA
    10/30/2025$88.00Underperform → In-line
    Evercore ISI
    Comerica Incorporated
    $CMA
    10/10/2025$93.00Outperform → Mkt Perform
    Keefe Bruyette
    Comerica Incorporated
    $CMA
    10/7/2025$83.00Underweight → Equal-Weight
    Morgan Stanley
    Comerica Incorporated
    $CMA
    9/25/2025$75.00Hold
    TD Cowen
    More analyst ratings

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Barakett Timothy R bought $4,723,500 worth of shares (50,000 units at $94.47) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/5/26 7:30:13 PM ET
    $KKR
    Investment Managers
    Finance

    Director Dillon Mary N bought $2,021,586 worth of shares (22,225 units at $90.96) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:01 PM ET
    $KKR
    Investment Managers
    Finance

    Co-Chief Executive Officer Bae Joseph Y bought $4,428,000 worth of shares (50,000 units at $88.56) (SEC Form 4)

    4 - KKR & Co. Inc. (0001404912) (Issuer)

    3/3/26 4:34:04 PM ET
    $KKR
    Investment Managers
    Finance

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on KKR with a new price target

    RBC Capital Mkts initiated coverage of KKR with a rating of Outperform and set a new price target of $137.00

    2/24/26 7:55:00 AM ET
    $KKR
    Investment Managers
    Finance

    KKR upgraded by HSBC Securities with a new price target

    HSBC Securities upgraded KKR from Hold to Buy and set a new price target of $144.00

    1/28/26 7:11:28 AM ET
    $KKR
    Investment Managers
    Finance

    KKR downgraded by TD Cowen with a new price target

    TD Cowen downgraded KKR from Buy to Hold and set a new price target of $131.00

    1/14/26 8:26:34 AM ET
    $KKR
    Investment Managers
    Finance

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Ew Healthcare Partners, L.P.

    4 - Venus Concept Inc. (0001409269) (Issuer)

    3/27/26 4:05:02 PM ET
    $VERO
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Altman Peter

    4 - BioCardia, Inc. (0000925741) (Issuer)

    3/26/26 8:05:40 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 3 filed by new insider Seth Arun

    3 - SIFY TECHNOLOGIES LTD (0001094324) (Issuer)

    3/26/26 5:38:54 PM ET
    $SIFY
    Computer Software: Programming Data Processing
    Technology

    $AIU
    $BCDA
    $CAPT
    $CLEU
    SEC Filings

    View All

    SEC Form 6-K filed by Roma Green Finance Limited

    6-K - Roma Green Finance Ltd (0001945240) (Filer)

    3/30/26 6:30:25 AM ET
    $ROMA
    Professional Services
    Consumer Discretionary

    Amendment: SEC Form SCHEDULE 13G/A filed by KKR & Co. Inc.

    SCHEDULE 13G/A - KKR & Co. Inc. (0001404912) (Subject)

    3/27/26 10:18:50 AM ET
    $KKR
    Investment Managers
    Finance

    Amendment: SEC Form SCHEDULE 13G/A filed by Forward Air Corporation

    SCHEDULE 13G/A - FORWARD AIR CORP (0000912728) (Subject)

    3/26/26 6:37:39 PM ET
    $FWRD
    Integrated Freight & Logistics
    Industrials

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Roma Green Finance Limited Announces US$100.0 Million Share Repurchase Program

    HONG KONG, March 30, 2026 (GLOBE NEWSWIRE) -- Roma Green Finance Limited ("ROMA" or the "Company") (NASDAQ:ROMA), an established provider of customized ESG, corporate governance and comprehensive sustainability and climate change solutions, including risk management solutions, today announced that its board of directors has authorized a share repurchase program, effective immediately, under which the Company may repurchase up to US$100.0 million of its Class A Ordinary Shares. The repurchase program will remain in effect until December 31, 2028, unless earlier modified, suspended, or terminated by the Company's board of directors. The Company's proposed repurchases may be made from time t

    3/30/26 6:30:00 AM ET
    $ROMA
    Professional Services
    Consumer Discretionary

    CoolIT Employees Share in $4.75 Billion Transaction as KKR Agrees to Sell to Ecolab

    KKR and its investors achieve 15x return 100% of CoolIT employees receive significant payouts KKR, a leading global investment firm, today announced that it has entered into a definitive agreement to sell CoolIT Systems ("CoolIT" or "the Company"), a global leader in liquid data center cooling, to Ecolab in a transaction valued at $4.75 billion. The sale will represent one of KKR's largest recent realizations, generating approximately 15x the original equity invested, inclusive of distributions. At the close of the transaction, all CoolIT employees will receive a substantial cash payout on their ownership in the Company. Mubadala Investment Company ("Mubadala") also served as a co-inves

    3/25/26 4:30:00 PM ET
    $KKR
    Investment Managers
    Finance

    Cumulus Media's Westwood One Presents Exclusive Multiplatform Audio Coverage of the 2026 NCAA® Women's Basketball Tournament

    March Madness® Broadcasts Connect College Hoops Fans across Multiple Platforms – 200+ Radio Stations, SiriusXM, NCAA March Madness Live™, WestwoodOneSports.com, the Westwood One Sports App, The Varsity Network App, Alexa-Enabled Devices, and TuneIn Premium ATLANTA, March 25, 2026 (GLOBE NEWSWIRE) -- Cumulus Media's (OTCQB:CMLS) Westwood One, one of America's largest audio networks and the official NCAA audio broadcast partner, will once again deliver comprehensive coverage of the NCAA Division I Women's Basketball Championship. Fans can follow every play—from the Sweet Sixteen and Elite Eight through the Final Four and National Championship. Coverage tips off Friday, March 27 with Sweet

    3/25/26 11:00:00 AM ET
    $CMLS
    Broadcasting
    Consumer Discretionary

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Financials

    Live finance-specific insights

    View All

    BioCardia Reports 2025 Business Highlights and Financial Results

    SUNNYVALE, Calif., March 24, 2026 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today reported financial results for the year ended December 31, 2025 and filed its annual report on Form 10-K with the Securities and Exchange Commission. The Company will host a corporate update conference call today, on Tuesday, March 24, 2026, at 4:30 PM ET, in which it will discuss business highlights. Call details and dial-in are provided below. Recent Business Highlights CardiAMP® autologous cell therapy in ischemic heart failure of reduced ejection fraction (BCDA-01) In parallel

    3/24/26 4:05:00 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    KKR Announces Intra-Quarter Monetization Activity Update for the First Quarter

    KKR today announced income from monetization activity in excess of $700 million with respect to the period from January 1, 2026 through March 23, 2026 based on information available as of today. The quarter-to-date monetization activity is made up of approximately 90% realized performance income and approximately 10% realized investment income. The quarter-to-date monetization activity is driven by a combination of public secondary sales and strategic transactions, as well as dividends and interest income. The estimate disclosed above is not intended to predict or represent total realized performance income, total realized investment income or total revenues for the full quarter ending

    3/23/26 4:15:00 PM ET
    $KKR
    Investment Managers
    Finance

    BioCardia to Host 2025 Financial Results and Corporate Update Conference Call on March 24, 2026

    SUNNYVALE, Calif., March 19, 2026 (GLOBE NEWSWIRE) -- BioCardia®, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced it will provide a corporate update and report its financial results for the year ended December 31, 2025 by conference call on Tuesday, March 24, 2026 at 4:30 PM EDT. Following management's formal remarks, there will be a question-and-answer session. Participants can register for the conference by navigating to https://dpregister.com/sreg/10207584/1039b7a7360. Please note that registered participants will receive their dial-in number upon registration. For those who have not

    3/19/26 7:47:51 PM ET
    $BCDA
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Versus Systems Inc.

    SC 13G/A - Versus Systems Inc. (0001701963) (Subject)

    11/14/24 7:30:32 PM ET
    $VS
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by Virax Biolabs Group Limited

    SC 13G/A - Virax Biolabs Group Ltd (0001885827) (Subject)

    11/14/24 4:46:07 PM ET
    $VRAX
    Biotechnology: In Vitro & In Vivo Diagnostic Substances
    Health Care

    Amendment: SEC Form SC 13G/A filed by Sunshine Biopharma Inc.

    SC 13G/A - Sunshine Biopharma Inc. (0001402328) (Subject)

    11/14/24 4:28:14 PM ET
    $SBFM
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AIU
    $BCDA
    $CAPT
    $CLEU
    Leadership Updates

    Live Leadership Updates

    View All

    TTM Technologies, Dutch Bros, Advanced Energy Industries, and American Healthcare REIT Set to Join S&P MidCap 400; Others to Join S&P SmallCap 600

    NEW YORK, Jan. 27, 2026 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400, S&P SmallCap 600: S&P SmallCap 600 constituent TTM Technologies Inc. (NASD: TTMI) will replace Civitas Resources Inc. (NYSE:CIVI) in the S&P MidCap 400, and Amneal Pharmaceuticals Inc. (NASD: AMRX) will replace TTM Technologies in the S&P SmallCap 600 effective prior to the opening of trading on Friday, January 30. S&P SmallCap 600 constituent SM Energy Co. (NYSE:SM) is acquiring Civitas Resources in a deal expected to be completed soon, pending final closing conditions. SM Energy will remain in the S&P SmallCap 600 post-merger.Dutch Bros Inc. (NYSE:BROS) will replace Potlatc

    1/27/26 6:02:00 PM ET
    $AEIS
    $AHR
    $AMRX
    Industrial Machinery/Components
    Technology
    Real Estate Investment Trusts
    Real Estate

    KKR-led Consortium Drives Further Investment in Sylvan

    Global investment firm KKR today announced the completion of an additional investment in Sylvan, a world-leading fungal biotechnology company (the "Company"), through funds managed by KKR with participation from new investors and a follow-on investment from existing investor, Novo Holdings, which increased its ownership stake in the Company as part of this round. Following the investment, KKR remains the majority investor in Sylvan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260120305013/en/ Founded in 1932, Sylvan is a world-leading mushroom spawn and fungal biotechnology company. The company seeks to harness the potential

    1/20/26 8:02:00 PM ET
    $KKR
    Investment Managers
    Finance

    Cumulus Media Appoints Carol Flaton to Board of Directors

    ATLANTA, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Cumulus Media Inc. (OTCQB:CMLS) today announced the appointment of Carol Flaton to its Board of Directors. Flaton's appointment follows the resignation of Joan Hogan Gillman from the Board. Both changes are effective January 15, 2026. "We are pleased to welcome Carol to our board," said Chairman Andrew W. Hobson. "She brings more than three decades of experience in financial services and governance, along with a strong track record of advising companies and serving on boards across a wide range of industries. Her insight and financial acumen will further strengthen the Board as the Company continues to execute its strategy." Hobson added, "We th

    1/15/26 8:01:00 AM ET
    $CMLS
    Broadcasting
    Consumer Discretionary